Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area Sort ascending
  • Date Posted
Job Title Site Location Division Business Functional Area Sort ascending Date Posted
Specialist - Quality Operations (APQR) INSURGENTES Mexico Operations Innovative Medicines Quality Sep 27, 2024
Quality Operations Specialist - Batch Release INSURGENTES Mexico Operations Innovative Medicines Quality Oct 07, 2024
Quality Assurance Specialist Murcia Spain Operations Innovative Medicines Quality Oct 16, 2024
Compliance & Quality System Manager Ivrea Italy Operations Innovative Medicines Quality Oct 17, 2024
(Senior) QA Operations Specialist Schaftenau Austria Operations Innovative Medicines Quality Sep 26, 2024
QC Analyst II / Labortechniker (m/w/d), Schaftenau, Tirol Schaftenau Austria Operations Innovative Medicines Quality Oct 07, 2024
AS&T Expert Schaftenau Austria Operations Innovative Medicines Quality Oct 14, 2024
Research & Development Quality Specialist Barcelona Gran Vía Spain Development Innovative Medicines Quality Oct 15, 2024
Compliance & Quality System Manager Ivrea Italy Operations Innovative Medicines Quality Oct 17, 2024
QC Site Manager / Responsable CQ - pharmacien adjoint SCL - H/F Saint-Cloud France Operations Innovative Medicines Quality Sep 03, 2024
Associate Director Data Ops & Analytics, RDQ Hyderabad (Office) India Development Innovative Medicines Quality Sep 03, 2024
Specialist - QA Ops - Manufacturing Mgmt Tuas South Avenue Singapore Operations Innovative Medicines Quality Sep 03, 2024
AS&T Hub Team Coordinator İstanbul Kurtköy Turkey Operations Innovative Medicines Quality Sep 03, 2024
eCompliance Manager Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Expert GMP Auditor Mumbai (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Senior GCP/PV Auditor Mumbai (Head Office) India Operations Innovative Medicines Quality Sep 03, 2024
Senior GCP/PV Auditor Mumbai (Head Office) India Operations Innovative Medicines Quality Sep 03, 2024
AS&T Expert - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
AS&T Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
QA Compliance Expert – Reg CMC Facilitator Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist - QA Ops - Manufacturing Mgmt Tuas South Avenue Singapore Operations Innovative Medicines Quality Sep 03, 2024
AS&T Specialist İstanbul Kurtköy Turkey Operations Innovative Medicines Quality Sep 03, 2024
QualityTeamLeader,QA Ops-Mfg Mgt(QA SF) Tuas South Avenue Singapore Operations Innovative Medicines Quality Sep 03, 2024
QC Analyst IV - Analytical Tuas South Avenue Singapore Operations Innovative Medicines Quality Jun 04, 2024
QC Analyst II. Basel (Land) Switzerland Operations Innovative Medicines Quality Sep 03, 2024
Senior QC Specialist Kundl Austria Operations Innovative Medicines Quality Sep 09, 2024
Analyst - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Quality Manager GCP / PV Hyderabad (Office) India Development Innovative Medicines Quality Sep 03, 2024
Specialist Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist – Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist – Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Associate, QA Officer Operations Sasayama Japan Operations Innovative Medicines Quality Sep 03, 2024
Head of Quality Carlsbad USA Operations Innovative Medicines Quality Sep 03, 2024
Specialist - Product Complaints - QOP Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
AS&T Specialist Schaftenau Austria Operations Innovative Medicines Quality Oct 24, 2024
QC Specialist II Schaftenau Austria Operations Innovative Medicines Quality Oct 25, 2024
Sachkundige Person Radiopharmazie (d/w/m) Munich (AAA Germany GmbH) Germany Operations Innovative Medicines Quality Apr 22, 2024
Innovation Manager Hyderabad (Office) India Operations Innovative Medicines Quality Apr 24, 2024
Analyst Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 20, 2024
Associate Director, Clinical QA East Hanover USA Development Innovative Medicines Quality Sep 24, 2024
QC Analyst/ Specialist Tuas South Avenue Singapore Operations Innovative Medicines Quality Sep 13, 2024
Quality Assurance Manager - QP/RP Amsterdam Netherlands Operations Innovative Medicines Quality Sep 17, 2024
QC Specialist II (m/f/d), Schaftenau, Tirol Schaftenau Austria Operations Innovative Medicines Quality Oct 03, 2024
QA Compliance Expert – Reg CMC Facilitator Schaftenau Austria Operations Innovative Medicines Quality Oct 03, 2024
Specialist upravljanja kakovosti dobaviteljev II (m/ž/d)/ QA supplier management specialist II (m/f/d) Ljubljana Slovenia Operations Innovative Medicines Quality Oct 03, 2024
Senior Quality Manager (m/f/d) Schaftenau Austria Development Innovative Medicines Quality Oct 03, 2024
QC Analyst IV Tuas South Avenue Singapore Operations Innovative Medicines Quality Oct 03, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only